India implemented the largest COVID-19 vaccination drive in the world, through which it vaccinated the majority of its population. Lessons from the Indian COVID-19 vaccination experience can be invaluable for other LMICs as well as for preparedness for future outbreaks. Our...
India, one of the world’s biggest suppliers of vaccines, is facing a COVID-19 vaccine crunch, partly due to an explosion of cases linked to new variants. This spells trouble for many countries relying on Indian-made vaccines supplied through the COVAX initiative for equitable access to ...
Experts have said that vaccines are the best way forward for India, whichlaunched its mass inoculation programin January. Since then, official data showed that only 11% of the population has received at least one vaccine dose while just 3.4% have completed the required two doses. The India...
COVAXIN®, India's indigenousCOVID-19 vaccineby Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech'sBSL-3 (Bio-Safety Level 3...
Phase-III efficacy trial was initiated in India on 25,800 volunteers and to date, ~22,500 participants have been vaccinated across the country. As per the data available currently, the vaccine is safe. Bharat Biotech has stockpiled 10 million doses of Covaxin and will be ready with another ...
“To be fair, I believe there have been two surprises. Unlike a year ago, when Covid-19 vaccine availability was being forecasted around mid-2021, the vaccine became available a bit earlier. Second, the lull in Covid-19 cases in India sort of set the complacency at all levels,” he ...
An effective vaccine against COVID-19 is need of the hour. India has been a hub for vaccine productions and Indian pharmaceutical companies have contributed immensely to the vaccine related projects running all over the world. Indian companies have also been pioneers in starting working on COVID-...
Additionally, the experts have also highlighted pre-existing co-morbidities, advanced maternal age, and high body mass Index as factors for severe COVID-19 in pregnancy,” the statement said. The NTAGI has recommended vaccination for pregnant women. The National Expert Group on Vaccine ...
But definitely the support will be for a completely indigenous vaccine candidate,” said Dr Renu Swarup, secretary, department of biotechnology, which is the nodal agency for Covid-19 vaccine development effort in the Prime Minister’s Task Force. Also Read: India tops 2...
According to the ministry, about 96 percent of the population who are 15 and above have received at least one COVID-19 vaccine dose while about 83 percent of this group have received two doses.■